Case Report: Identification of Potential Prognosis-Related TP53 Mutation and BCL6-LPP Fusion in Primary Pituitary Lymphoma by Next Generation Sequencing: Two Cases
ConclusionThe gene mutation of TP53 and BCL6 may be identified as a marker responsible for prognostic difference in patients with PPL. Genetic analysis may provide a novel approach for precise management and prognosis prediction.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
More News: Chemotherapy | Endocrinology | Genetics | Lymphoma | Primary CNS Lymphoma | Rare Diseases